Sign Up
OverviewAPI
Health-care companies experienced a decline as investors sought out high-risk stocks in a 'risk-on' speculative phase for the stock market, with Novo Nordisk and Eli Lilly shares rising while CEL-SCI shares fell.

Ask a question